Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cough medicine
Biotech
Roche culls cough candidate, pivots KRAS program in Q3 update
Roche axed the cough program as part of a wider pullback from prospects that fell short of the bar for further development.
Nick Paul Taylor
Oct 23, 2024 6:35am
After $2B acquisition, GSK sends some Bellus workers packing
Mar 22, 2024 11:08am
GSK tips 12 blockbuster launches to soften HIV patent loss
Jan 31, 2024 7:45am
Merck’s cough drug gefapixant rejected by FDA for second time
Dec 21, 2023 5:38am
After Merck's cough drama, GSK knew what to do with Bellus asset
Nov 30, 2023 8:00am
UPDATE: FDA AdComm votes against Merck's cough med
Nov 17, 2023 4:53pm